{"id":545599,"date":"2024-07-11T19:54:05","date_gmt":"2024-07-12T02:54:05","guid":{"rendered":"https:\/\/nai500.com\/blog\/2024\/07\/%e7%a5%9e%e5%a5%87%e7%9a%84glp-1%e9%9d%b6%e5%90%91%e8%8d%af%e7%89%a9%ef%bc%8c%e5%8d%b3%e5%b0%86%e5%ad%95%e8%82%b2%e6%96%b0%e7%9a%84%e5%87%8f%e8%82%a5%e8%8d%af%e5%8f%8c%e9%9b%84\/"},"modified":"2024-07-11T19:54:44","modified_gmt":"2024-07-12T02:54:44","slug":"glp-1%e9%9d%b6%e5%90%91%e8%97%a5%e7%89%a9-%e5%ad%95%e8%82%b2%e6%96%b0%e7%9a%84%e6%b8%9b%e8%82%a5%e8%97%a5%e9%9b%99%e9%9b%84","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2024\/07\/glp-1%e9%9d%b6%e5%90%91%e8%97%a5%e7%89%a9-%e5%ad%95%e8%82%b2%e6%96%b0%e7%9a%84%e6%b8%9b%e8%82%a5%e8%97%a5%e9%9b%99%e9%9b%84\/","title":{"rendered":"\u795e\u5947\u7684GLP-1\u9776\u5411\u85e5\u7269\uff0c\u5373\u5c07\u5b55\u80b2\u65b0\u7684\u201c\u6e1b\u80a5\u85e5\u96d9\u96c4\u201d"},"content":{"rendered":"<p>\u8fd1\u5e74\u4f86\uff0cGLP-1\u9776\u5411\u85e5\u7269\u5728\u80a5\u80d6\u6cbb\u7642\u9818\u57df\u6210\u70ba\u4e86\u7099\u624b\u53ef\u71b1\u7684\u7814\u7a76\u65b9\u5411\u3002\u7e7c\u8afe\u548c\u8afe\u5fb7Novo Nordisk\uff08NYSE:NVO\uff09\u548c\u79ae\u4f86Eli Lilly and Co\uff08NYSE:LLY\uff09\u5404\u81ea\u63a8\u51fa\u6e1b\u80a5\u85e5Wegovy\u548cZepbound\u4e4b\u5f8c\uff0c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=ALT\">Altimmune Inc.\uff08NASDAQ:ALT\uff09<\/a>\u548cViking Therapeutics Inc\uff08NASDAQ:VKTX\uff09\u9019\u5169\u5bb6\u751f\u7269\u6280\u8853\u516c\u53f8\u4e5f\u5728\u9019\u4e00\u9818\u57df\u5c55\u73fe\u51fa\u5f37\u5927\u7684\u7af6\u722d\u529b\u3002<\/p>\n<p>\u5982\u679c\u8aaa\u8afe\u548c\u8afe\u5fb7\u548c\u79ae\u4f86\u662f\u76ee\u524d\u7f8e\u80a1\u5e02\u5834\u4e0a\u7684\u201c\u6e1b\u80a5\u85e5\u96d9\u96c4\u201d\uff0cAltimmune\u548cViking Therapeutics\u6709\u671b\u6210\u70ba\u672a\u4f86\u7684\u96d9\u96c4\uff0c\u4f9d\u64da\u662f\u9019\u5169\u5bb6\u751f\u7269\u79d1\u6280\u516c\u53f8\u90fd\u64c1\u6709\u5f37\u5927\u5be6\u529b\u7684\u5728\u7814\u6e1b\u80a5\u85e5\uff0c\u800c\u4e14\u73fe\u91d1\u5145\u8db3\u3002<\/p>\n<h2>Viking Therapeutics\uff1a\u6e1b\u80a5\u901f\u5ea6\u66f4\u5feb<\/h2>\n<p>Viking Therapeutics\u7684\u4e3b\u8981\u5019\u9078\u85e5\u7269VK2735\u5df2\u7d93\u5728\u51762b\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\u53d6\u5f97\u4e86\u986f\u8457\u6210\u6548\u3002\u6578\u64da\u986f\u793a\uff0c\u8207\u76ee\u524d\u5e02\u5834\u4e0a\u7684\u6e1b\u80a5\u85e5\u76f8\u6bd4\uff0cVK2735\u7684\u6e1b\u80a5\u901f\u5ea6\u660e\u986f\u66f4\u5feb\uff0c\u4e14\u526f\u4f5c\u7528\u76f8\u7576\u3002\u7d93\u904e\u50c513\u5468\u7684\u6cbb\u7642\u5f8c\uff0c\u53d7\u8a66\u8005\u7d93\u5b89\u6170\u5291\u8abf\u6574\u5f8c\u7684\u9ad4\u91cd\u5e73\u5747\u6e1b\u5c11\u4e8613.1%\u3002<\/p>\n<p>\u66f4\u4ee4\u4eba\u632f\u596e\u7684\u662f\uff0cVK2735\u4e26\u672a\u986f\u793a\u51fa\u6e1b\u80a5\u6548\u679c\u7684\u201c\u5e73\u81fa\u671f\u201d\uff0c\u9019\u610f\u5473\u8457\u6cbb\u7642\u6709\u671b\u5e36\u4f86\u9ad4\u91cd\u7684\u6301\u7e8c\u6e1b\u8f15\u3002\u6b64\u5916\uff0cViking\u7684VK2735\u53e3\u670d\u85e5\u7269\u6b63\u8655\u65bc\u65e9\u671f\u7814\u767c\u968e\u6bb5\uff0c\u800c\u4e14\u521d\u671f\u6578\u64da\u8868\u73fe\u4e5f\u4e0d\u5f31\u65bc\u6ce8\u5c04\u5291\u3002\u76ee\u524d\u5e02\u5834\u4e0a\u92b7\u552e\u706b\u7206\u7684Wegovy\u548cZepbound\u90fd\u662f\u6ce8\u5c04\u5291\uff0c\u5982\u679c\u8a72\u516c\u53f8\u7684\u53e3\u670d\u6e1b\u80a5\u85e5\u6210\u529f\u4e0a\u5e02\uff0c\u6191\u85c9\u8457\u4fbf\u5229\u6027\u9019\u6b3e\u85e5\u7121\u7591\u53ef\u4ee5\u7372\u5f97\u66f4\u5927\u7684\u5e02\u5834\u4efd\u984d\u3002<\/p>\n<p>Viking\u76ee\u524d\u8cc7\u91d1\u5be6\u529b\u975e\u5e38\u96c4\u539a\uff0c\u64c1\u67099.63\u5104\u7f8e\u5143\u7684\u73fe\u91d1\u3001\u77ed\u671f\u6295\u8cc7\u53ca\u73fe\u91d1\u7b49\u50f9\u7269\uff0c\u800c\u904e\u53bb12\u500b\u6708\u7684\u7e3d\u652f\u51fa\u50c5\u70ba1.14\u5104\u7f8e\u5143\u3002\u516c\u53f8\u6c92\u6709\u8ca0\u50b5\uff0c\u9019\u4e5f\u610f\u5473\u8457VK2735\u7684\u7814\u767c\u548c\u5546\u696d\u5316\u6c92\u6709\u878d\u8cc7\u7684\u9700\u6c42\u3002<\/p>\n<h2>Altimmune\uff1a\u6e1b\u8102\u4e0d\u6e1b\u808c<\/h2>\n<p>\u8207Viking\u76f8\u6bd4\uff0cAltimmune\u7684GLP-1\u7ba1\u7dda\u7565\u5fae\u9818\u5148\u534a\u6b65\u3002\u8a72\u516c\u53f8\u7684\u4e3b\u8981\u5019\u9078\u85e5\u7269\u525b\u525b\u5b8c\u62102\u671f\u81e8\u5e8a\u8a66\u9a57\uff0c\u9810\u8a08\u5c07\u5728\u7b2c\u4e09\u5b63\u5ea6\u8207\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6703\u9762\uff0c\u63a2\u8a0e\u9032\u51653\u671f\u81e8\u5e8a\u7684\u4e8b\u5b9c\u3002<\/p>\n<p>\u76ee\u524dAltimmune\u767c\u4f48\u7684\u6578\u64da\u4e26\u672a\u6e05\u6670\u986f\u793a\u5b83\u7684\u5019\u9078\u85e5\u7269\u6e1b\u80a5\u901f\u5ea6\u512a\u65bcViking\u7684VK2735\uff0c\u4f46\u540c\u6a23\u672a\u986f\u793a\u5e73\u81fa\u671f\u30022\u671f\u8a66\u9a57\u768448\u5468\u5167\uff0c\u6700\u9ad8\u5291\u91cf\u7d44\u5e73\u5747\u6e1b\u91cd15.6%\u3002\u4e0d\u904e\u5c24\u5176\u503c\u5f97\u4e00\u63d0\u7684\u662f\uff0cAltimmune\u7684\u5019\u9078\u85e5\u7269\u6e1b\u8102\u4e0d\u6e1b\u808c\uff0c\u9019\u662f\u5176\u4ed6\u7af6\u722d\u85e5\u7269\u7121\u6cd5\u6bd4\u64ec\u7684\u512a\u52e2\u3002\u6211\u5011\u77e5\u9053\uff0c\u808c\u8089\u6d41\u5931\u6703\u5c0e\u81f4\u5404\u7a2e\u5065\u5eb7\u554f\u984c\uff0c\u56e0\u6b64\u5982\u679c\u901a\u904e\u5be9\u6279\uff0c\u8a72\u5019\u9078\u85e5\u7269\u5c07\u6210\u70ba\u8001\u5e74\u4eba\u3001\u808c\u8089\u7dad\u8b77\u969c\u7919\u8005\u4ee5\u53ca\u884c\u52d5\u4e0d\u4fbf\u4eba\u58eb\u7684\u9996\u9078\u6cbb\u7642\u65b9\u6848\u3002<\/p>\n<p>Altimmune\u76ee\u524d\u4e5f\u6c92\u6709\u8ca0\u50b5\uff0c\u64c1\u67091.82\u5104\u7f8e\u5143\u7684\u73fe\u91d1\u3001\u73fe\u91d1\u7b49\u50f9\u7269\u53ca\u6295\u8cc7\uff0c\u904e\u53bb12\u500b\u6708\u7684\u7e3d\u652f\u51fa\u70ba8900\u842c\u7f8e\u5143\u3002\u96d6\u7136\u5728\u85e5\u7269\u5546\u696d\u5316\u524d\u9700\u8981\u984d\u5916\u878d\u8cc7\uff0c\u4f46\u77ed\u671f\u5167\u8ca1\u52d9\u72c0\u6cc1\u5c1a\u5c6c\u7a69\u5b9a\u3002<\/p>\n<h2>Viking\u7684\u98a8\u96aa\u66f4\u4f4e<\/h2>\n<p>Viking Therapeutics\u548cAltimmune\u90fd\u662f\u975e\u5e38\u512a\u8cea\u7684\u6e1b\u80a5\u85e5\u6f5b\u529b\u80a1\uff0c\u5b83\u5011\u7684\u5728\u7814GLP-1\u9776\u5411\u85e5\u7269\u5747\u6709\u671b\u5728\u672a\u4f86\u5169\u5e74\u5167\u5b8c\u6210\u81e8\u5e8a\u8a66\u9a57\u4e26\u7372\u6279\u4e0a\u5e02\u3002\u4f46\u662f\u76f8\u6bd4\u4e4b\u4e0b\uff0cViking\u7684\u80a1\u7968\u4f30\u503c\u6700\u8fd1\u62ac\u5347\u660e\u986f\uff0c\u4f46\u8a72\u516c\u53f8\u73fe\u91d1\u5132\u5099\u66f4\u52a0\u5145\u8db3\uff0c\u7814\u767c\u7ba1\u7dda\u66f4\u52a0\u591a\u5143\u5316\uff0c\u62b5\u79a6\u4e0d\u78ba\u5b9a\u6027\u7684\u80fd\u529b\u66f4\u5f37\u3002\u9019\u6a23\u770b\u4f86\uff0cAltimmune\u56e0\u70ba\u5168\u62bcGLP-1\u9776\u5411\u85e5\u7269\uff0c\u98a8\u96aa\u66f4\u9ad8\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u8fd1\u5e74\u4f86\uff0cGLP-1\u9776\u5411\u85e5\u7269\u5728\u80a5\u80d6\u6cbb\u7642\u9818\u57df\u6210\u70ba\u4e86\u7099\u624b\u53ef\u71b1\u7684\u7814\u7a76\u65b9\u5411\u3002\u7e7c\u8afe\u548c\u8afe\u5fb7Novo Nordisk\uff08NYSE [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":448885,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[2156,927,2141,564],"class_list":["post-545599","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-2156","tag-927","tag-2141","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/545599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=545599"}],"version-history":[{"count":3,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/545599\/revisions"}],"predecessor-version":[{"id":545602,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/545599\/revisions\/545602"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/448885"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=545599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=545599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=545599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}